BARCLAYS PLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 312069 LONDON, X0

Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$159,745,957

-$82,162,216 QoQ

Shares Held

256,192

-18.2% QoQ

Ownership

0.249%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#55

of 1,322 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Dec 31, 2024

CallValue

$6,482,203

CallShares

9,100

PutValue

$2,136,990

PutShares

3,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. REGN ranks #2 (9.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc. This page	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

All Filings in REGN

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$159,745,957	256,192	-18.2%	Shares	Defined	2026-08-14
2026-03-31	$241,908,173	313,093	+0.6%	Shares	Defined	2026-05-15
2025-12-31	$240,180,470	311,167	-4.5%	Shares	Defined	2026-02-13
2025-09-30	$183,255,599	325,921	-32.5%	Shares	Sole	2026-03-31
2025-06-30	$253,588,650	483,026	+50.3%	Shares	Sole	2026-02-27
2025-03-31	$203,814,248	321,357	-16.6%	Shares	Defined	2026-03-17
2024-12-31	$274,373,843	385,178	-6.7%	Shares	Sole	2026-03-19
2024-12-31	$6,482,203	9,100	+2.2%	Call	Sole	2026-03-19
2024-12-31	$2,136,990	3,000	-16.7%	Put	Sole	2026-03-19
2024-09-30	$433,896,154	412,747	+17.9%	Shares	Defined	2026-03-31
2024-09-30	$9,356,036	8,900	+27.1%	Call	Sole	2026-03-31
2024-09-30	$3,784,464	3,600	-91.9%	Put	Sole	2026-03-31
2024-06-30	$367,981,366	350,115	+1.9%	Shares	Sole	2026-03-23
2024-03-31	$330,728,887	343,618	+15.2%	Shares	Sole	2026-03-24
2023-12-31	$261,938,573	298,237	+17.0%	Shares	Defined	2026-03-24
2023-09-30	$209,747,813	254,870	-8.6%	Shares	Defined	2026-03-26
2023-06-30	$200,461,161	278,984	+58.2%	Shares	Defined	2026-03-27
2023-03-31	$144,856,309	176,295	-22.7%	Shares	Defined	2026-03-30
2022-12-31	$164,625,257	228,174	+46.4%	Shares	Defined	2026-03-30
2022-09-30	$107,343,853	155,826	+29.6%	Shares	Defined	2022-11-03
2022-06-30	$4,137,910	7,000	-53.3%	Call	Sole	2022-08-12
2022-06-30	$26,305,285	44,500	+48.3%	Put	Sole	2022-08-12
2022-06-30	$71,078,651	120,242	-25.2%	Shares	Defined	2022-08-12
2022-03-31	$112,298,950	160,790	-67.2%	Shares	Sole	2022-05-16
2021-12-31	$309,197,874	489,609	+54.3%	Shares	Defined	2022-02-14
2021-09-30	$192,000,616	317,262	+78.4%	Shares	Sole	2021-11-09
2021-06-30	$99,307,293	177,798	+12.4%	Shares	Sole	2021-08-13
2021-03-31	$14,194,200	30,000	+226.1%	Put	Sole	2021-05-13
2021-03-31	$7,097,100	15,000	+689.5%	Call	Sole	2021-05-13
2021-03-31	$74,866,359	158,233	-8.6%	Shares	Defined	2021-05-13
2020-12-31	$4,444,612	9,200	+43.8%	Put	Sole	2021-02-11
2020-12-31	$83,665,954	173,182	+20.5%	Shares	Defined	2021-02-11
2020-09-30	$80,422,471	143,668	-13.9%	Shares	Sole	2020-11-12
2020-09-30	$1,063,582	1,900	-92.3%	Call	Sole	2020-11-12
2020-09-30	$3,582,592	6,400	-25.6%	Put	Sole	2020-11-12
2020-06-30	$5,363,390	8,600	-70.7%	Put	Sole	2020-08-12
2020-06-30	$104,054,754	166,848	+1.0%	Shares	Sole	2020-08-12
2020-03-31	$80,689,919	165,250	—	Shares	Sole	2020-05-13
2020-03-31	$12,109,592	24,800	—	Call	Sole	2020-05-13
2020-03-31	$14,355,726	29,400	—	Put	Sole	2020-05-13
No filing history on record for this holder in this stock.